Payment overview · 2025
General Payments
$115.69
1 reported records · 1 companies
Healthcare provider profile · identity verified
Janet Eileen Morgan, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · INDEPENDENCE, MO · NPI 1063403525
Verified facts
What the public records show
CMS Open Payments records show Janet Eileen Morgan, M.D. received $115.69 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $115.69 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $115.69 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $115.69 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 410 | 36 |
| Atorvastatin Calcium | Atorvastatin Calcium | 328 | 45 |
| Furosemide | Furosemide | 304 | 43 |
| Eliquis | Apixaban | 232 | 20 |
| Potassium Chloride | Potassium Chloride | 213 | 25 |
| Pantoprazole Sodium | Pantoprazole Sodium | 185 | 29 |
| Trazodone Hcl | Trazodone Hcl | 159 | 24 |
| Celecoxib | Celecoxib | 151 | 21 |
| Spironolactone | Spironolactone | 148 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 133 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 133 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 122 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 117 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 117 | 21 |
| Divalproex Sodium | Divalproex Sodium | 111 | suppressed |
| Gabapentin | Gabapentin | 110 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 101 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 99 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 97 | 12 |
| Levetiracetam | Levetiracetam | 94 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 94 | 14 |
| Metformin Hcl | Metformin Hcl | 90 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 90 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 86 | 20 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 85 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 84 | 14 |
| Carvedilol | Carvedilol | 80 | 13 |
| Buspirone Hcl | Buspirone Hcl | 79 | 13 |
| Mirtazapine | Mirtazapine | 76 | 13 |
| Losartan Potassium | Losartan Potassium | 73 | 12 |
| Ezetimibe | Ezetimibe | 72 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 71 | 12 |
| Olanzapine | Olanzapine | 71 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 12 |
| Lorazepam | Lorazepam | 68 | suppressed |
| Amlodipine Besylate | Amlodipine Besylate | 67 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 64 | suppressed |
| Lactulose | Lactulose | 63 | suppressed |
| Bupropion Xl | Bupropion Hcl | 62 | suppressed |
| Gemtesa | Vibegron | 59 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 59 | suppressed |
| Prednisone | Prednisone | 58 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 58 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 57 | suppressed |
| Xifaxan | Rifaximin | 57 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 56 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 55 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 55 | suppressed |
| Baclofen | Baclofen | 53 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 53 | suppressed |
| Primidone | Primidone | 53 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 52 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 52 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 51 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | suppressed |
| Famotidine | Famotidine | 50 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 50 | 11 |
| Novolog Flexpen | Insulin Aspart | 50 | 13 |
| Risperidone | Risperidone | 50 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 48 | suppressed |
| Finasteride | Finasteride | 47 | suppressed |
| Lisinopril | Lisinopril | 46 | suppressed |
| Allopurinol | Allopurinol | 45 | suppressed |
| Jardiance | Empagliflozin | 44 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 44 | suppressed |
| Fenofibrate | Fenofibrate | 43 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 42 | suppressed |
| Valsartan | Valsartan | 42 | suppressed |
| Clonazepam | Clonazepam | 41 | suppressed |
| Bumetanide | Bumetanide | 39 | suppressed |
| Diazepam | Diazepam | 37 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | suppressed |
| Latanoprost | Latanoprost | 32 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 32 | suppressed |
| Pregabalin | Pregabalin | 31 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 29 | suppressed |
| Haloperidol | Haloperidol | 29 | suppressed |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Simvastatin | Simvastatin | 26 | suppressed |
| Alprazolam | Alprazolam | 25 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 24 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 24 | suppressed |
| Fluconazole | Fluconazole | 23 | suppressed |
| Lamotrigine | Lamotrigine | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 22 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 22 | suppressed |
| Clozapine | Clozapine | 22 | suppressed |
| Entacapone | Entacapone | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 22 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 12 |
| Acetic Acid | Acetic Acid | 19 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Fentanyl | Fentanyl | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Xarelto | Rivaroxaban | 19 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 18 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 12 |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 16 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 12 |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Lacosamide | Lacosamide | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Trospium Chloride | Trospium Chloride | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Azithromycin | Azithromycin | 11 | suppressed |
| Bicalutamide | Bicalutamide | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Silodosin | Silodosin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $115.69 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error